The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2017 | Patient-physician communication: what can be improved?
Good communication between the patient and their clinical team is essential for positive outcomes. Aliki Xochelli, MD, PhD, from the the Centre for Research & Technology, Thermi, Greece, takes us through the results from a qualitative study specifically focusing on communication and support for patients with chronic lymphocytic lymphoma (CLL) presented at the European Hematology Association (EHA) 2017 meeting. Here, Dr Aliki presents the findings from the ‘needs’ phase of the study, which reveal the gaps in communications skills of physicians in Greece.
